Abstract:Background: Gastric-cancer is a heterogeneous type of neoplastic disease and it lacks appropriate therapeutic options. There is an urgent need for the development of innovative pharmacological strategies, particularly in consideration of the potential stratified/personalized treatment of this tumor. All-Trans Retinoic-acid (ATRA) is one of the active metabolites of vitamin-A. This natural compound is the first example of clinically approved cyto-differentiating agent, being used in the treatment of acute promyelocytic leukemia. ATRA may have significant therapeutic potential also in the context of solid tumors, including gastric-cancer. The present study provides pre-clinical evidence supporting the use of ATRA in the treatment of gastric-cancer using high-throughput approaches. Methods: We evaluated the anti-proliferative action of ATRA in 27 gastric-cancer cell-lines and tissue-slice cultures from 13 gastric-cancer patients. We performed RNA-sequencing studies in 13 cell-lines exposed to ATRA. We used these and the gastric-cancer RNA-sequencing data of the TCGA/CCLE datasets to conduct multiple computational analyses. Results: Profiling of our large panel of gastric-cancer cell-lines for their quantitative response to the anti-proliferative effects of ATRA indicate that approximately half of the cell-lines are characterized by sensitivity to the retinoid. The constitutive transcriptomic profiles of these cell-lines permitted the construction of a model consisting of 42 genes, whose expression correlates with ATRA-sensitivity. The model predicts that 45% of the TCGA gastric-cancers are sensitive to ATRA. RNA-sequencing studies performed in retinoid-treated gastric-cancer cell-lines provide insights into the gene-networks underlying ATRA anti-tumor activity. In addition, our data demonstrate that ATRA exerts significant immune-modulatory effects, which seem to be largely controlled by IRF1 up-regulation. Finally, we provide evidence of a feed-back loop between IRF1 and DHRS3, another gene which is up-regulated by ATRA. Conclusions: ATRA is endowed with significant therapeutic potential in the stratified/personalized treatment gastric-cancer. Our data represent the fundaments for the design of clinical trials focusing on the use of ATRA in the personalized treatment of this heterogeneous tumor. Our gene-expression model will permit the development of a predictive tool for the selection of ATRA-sensitive gastric-cancer patients. The immune-regulatory responses activated by ATRA suggest that the retinoid and immune-checkpoint inhibitors constitute rational combinations for the management of gastric-cancer.

Growth Inhibition of Gastric Cancer Cells by All-Trans Retinoic Acid Through Arresting Cell Cycle Progression

Antitumor Effects Of All-Trans Retinoic Acid And Its Synergism With Gemcitabine Are Associated With Downregulation Of P21-Activated Kinases In Pancreatic Cancer

Effect of all--retinoic acid on mRNA binding protein p62 in human gastric cancer cells

Effect of all-trans-retinoic acid on mRNA binding protein p62 in human gastric cancer cells

Effect of Allitridi on Cyclin D1 and P27kip1 Protein Expression in Gastric Carcinoma BGC823 Cells

Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms

All-Trans Retinoic Acid Prevents the Progression of Gastric Precancerous Lesions by Regulating Disordered Retinoic Acid Metabolism

1 α ,25 (OH)2D3 inhibits proliferation of gastric cancer cell line by arresting cell cycle

ATRA promotes PD-L1 expression to control gastric cancer immune surveillance

Effect of All-Trans Retinoic Acid on Proliferation of Human Epidermoid Carcinoma (A431) Cells

All-trans retinoic acid-mediated miR-30a up-regulation suppresses autophagy and sensitizes gastric cancer cells to cisplatin

All Trans-Retinoic Acid (Atra) Induces Re-Differentiation Of Early Transformed Breast Epithelial Cells

All-Trans Retinoic Acid Inhibits Migration, Invasion And Proliferation, And Promotes Apoptosis In Glioma Cells In Vitro

Synthesis And Antiproliferative Activity Of Novel All-Trans-Retinoic Acid-Podophyllotoxin Conjugate Towards Human Gastric Cancer Cells

All-trans-retinoic Acid Induces Cell Growth Arrest in a Human Medulloblastoma Cell Line

Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1

DOK1/PPARgamma Pathway Mediates Anti-Tumor Ability of All-Trans Retinoic Acid in Breast Cancer MCF-7 Cells.

The effect of all-trans retinoic acid on the proliferation of neuroblastoma SY5Y cells

Affect of All-trans Retinoic Acid on Expression of BMI-1 in A431 Cell Line

Identification of Retinoic Acid As an Inhibitor of Transcription Factor Nrf2 Through Activation of Retinoic Acid Receptor Alpha

Arrest of human gastric cancer AGS cells by tangeretin via CyclinB1 upregulation and inhibition of ERK phosphorylation